Shandong Sito Bio-technology Co Ltd Asset Resilience Ratio

Latest as of September 2020: 0.35%

Shandong Sito Bio-technology Co Ltd asset resilience ratio. Shandong Sito Bio-technology Co Ltd (300583) has an Asset Resilience Ratio of 0.35% as of September 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300583 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥10.00 Million

≈ $1.46 Million USD Cash + Short-term Investments

Total Assets

CN¥2.87 Billion

≈ $419.27 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Shandong Sito Bio-technology Co Ltd (2017–2019)

Asset resilience ratio of Shandong Sito Bio-technology Co Ltd from 2017 to 2019. This chart shows how Shandong Sito Bio-technology Co Ltd's Asset Resilience Ratio has changed over time. See 300583 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Shandong Sito Bio-technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shandong Sito Bio-technology Co Ltd (300583) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥10.00 Million	0.35%
Total Liquid Assets	CN¥10.00 Million	0.35%

Asset Resilience Insights

Limited Liquidity: Shandong Sito Bio-technology Co Ltd maintains only 0.35% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shandong Sito Bio-technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shandong Sito Bio-technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	2.50%
BB Biotech AG SW:BION	Biotechnology	92.97%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.57%
Eupraxia Pharmaceuticals Inc TO:EPRX	Biotechnology	25.13%
Cabio Biotech Wuhan Co Ltd SHG:688089	Biotechnology	3.60%

Shandong Sito Bio-technology Co Ltd Asset Resilience Ratio by Year (2017–2019)

Shandong Sito Bio-technology Co Ltd asset resilience ratio by year from 2017 to 2019. The table below shows the annual Asset Resilience Ratio data for Shandong Sito Bio-technology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	6.81%	CN¥203.36 Million ≈ $29.76 Million	CN¥2.99 Billion ≈ $437.13 Million	-14.84pp
2018-12-31	21.64%	CN¥561.57 Million ≈ $82.18 Million	CN¥2.59 Billion ≈ $379.65 Million	-5.96pp
2017-12-31	27.61%	CN¥558.88 Million ≈ $81.78 Million	CN¥2.02 Billion ≈ $296.26 Million	--

pp = percentage points

About Shandong Sito Bio-technology Co Ltd

SHE:300583 China Biotechnology

Market Cap

$327.56 Million

CN¥2.24 Billion CNY

Market Cap Rank

#14200 Global

#4199 in China

Share Price

CN¥11.80

Change (1 day)

-2.56%

52-Week Range

CN¥10.95 - CN¥16.07

All Time High

CN¥50.68